China Medical System Reports Increase in H1 Net Profit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 19 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Financial Performance: China Medical System Holdings reported a net profit of approximately RMB 0.93 billion for the first half of the year, marking a 3.1% increase year-on-year, with revenue reaching about RMB 4.00 billion, up 10.8%.
Sales Projection: If all medicines were sold directly by the company, projected revenue would be around RMB 4.67 billion, reflecting an 8.9% year-on-year growth.
Strategic Planning: The company has been implementing its New CMS blueprint since 2018, aiming for solid operating results and innovation outcomes by the first half of 2025.
Earnings Information: For additional earnings news and stock information, readers are directed to visit rttnews.com.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
